Skip to content

A clinical trial to evaluate the effect of Shatavari ghrita on fetal outcome w.s.r. to birth weight

An open label randomized controlled clinical trial to evaluate the effect of Shatavari ghrita during pregnancy on fetal outcome w.s.r. to birth weight

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023448
Enrollment
30
Registered
2020-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Shatavari Ghrita along with routine antenatal care: Shatavari Ghrita 10 ml BD for 5 months(12-14 weeks onwards to 34 weeks)
Iron capsule (ferrous ascorbate 100 mg,folic acid 1.5 mg)OD for 6 months (12 weeks onwards till delivery)
calcium tablet(calcium carbonate and vit. D3) 500 mg OD for 6 months (12 weeks onwards till delivery) Control Intervention1: Routine antenatal care: Iron capsule (ferrous ascorbate 100 mg,folic acid 1
calcium tablet(calcium carbonate and vit. D3) 500 mg OD for 6 months (12 weeks onwards till delivery)

Sponsors

All India Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Primi and second gravida with gestational age 12 to 14 weeks;able and willing to participate and provide signed informed consent

Exclusion criteria

Exclusion criteria: Severe anaemia Hb <7 gm/dl; pregnancy complicated by placenta praevia, coexisting fibroid, any malignancy,twins; pregnancy complicated with diseases such as hypo or hyperthyroidism, cardiovascular diseases, diabetes.

Design outcomes

Primary

MeasureTime frame
Evaluate the effect of oral administration of Shatavari ghrita during pregnancy on fetal outcome w.s.r. to birth weightTimepoint: Baby fetal weight by USG; Birth weight will be noted at the time of delivery and on 10th after delivery; APGAR score

Secondary

MeasureTime frame
Evaluate the effect of oral administration of Shatavari ghrita in garbhini i.e. to minimize the complications of pregnancyTimepoint: Every 15th day in 4th to 6th month;every 8th day in 7th to 9th month; Gestational age at the time of labour; Mode of delivery; Duration of labour

Countries

India

Contacts

Public ContactNidhi Tahlan

All India Institute Of Ayurveda

sujatadkadam@gmail.com9890305370

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026